TY  - JOUR
AU  - Saggar, Rajan
AU  - Xue, Ying Ying
AU  - Ardehali, Abbas
AU  - Stripp, Barry
AU  - Ross, David
AU  - Lynch, Joseph P.
AU  - Elashoff, Robert
AU  - Weigt, S. Samuel
AU  - Belperio, John
AU  - Shino, Michael
AU  - Derhovanessian, Ariss
AU  - Sayah, David
PY  - 2018
DA  - 2018/11/30
TI  - The Impact of Allograft CXCL9 during Respiratory Infection on the Risk of Chronic Lung Allograft Dysfunction
JO  - OBM Transplantation
SP  - 029
VL  - 02
IS  - 04
AB  - The long term clinical significance of respiratory infections after lung transplantation remains uncertain. In this retrospective single-center cohort study of 441 lung transplant recipients, we formally evaluate the association between respiratory infection and chronic lung allograft dysfunction (CLAD). We furthermore hypothesized that bronchoalveolar lavage fluid (BALF) CXCL9 concentrations are augmented during respiratory infections, and that episodes of infection with elevated BALF CXCL9 are associated with greater CLAD risk.  In univariable and multivariable models adjusted for other histopathologic injury patterns, respiratory infection, regardless of the causative organism, was a strong predictor of CLAD development (adjusted HR 1.8 95% CI 1.3-2.6). Elevated BALF CXCL9 concentrations during respiratory infections markedly increased CLAD risk in a dose-response manner. An episode of respiratory infection with CXCL9 concentrations greater than the 25th, 50th, and 75th percentile had adjusted HRs for CLAD of 1.8 (95% CI 1.1-2.8), 2.4 (95% CI 1.4-4.0) and 4.4 (95% CI 2.4-8.0), respectively. Thus, we demonstrate that respiratory infections, regardless of the causative organism, are strong predictors of CLAD development. We furthermore demonstrate for the first time, the prognostic importance of BAL CXCL9 concentrations during respiratory infections on the risk of subsequent CLAD development.
SN  - 2577-5820
UR  - https://doi.org/10.21926/obm.transplant.1804029
DO  - 10.21926/obm.transplant.1804029
ID  - Saggar2018
ER  -